Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
discard if cloudy or contains particles
While the peptide does not increase IGF-1, caution is warranted given the theoretical relationship between growth factors and cancer progression
WADA 2026 Prohibited List Status (Section S0) Retatrutide is not currently named explicitly on the World Anti-Doping Agency 2025 or 2026 Prohibited Lists but falls within section S0 (Non-Approved Substances), which covers any pharmacological substance not currently approved by a governmental health authority for human therapeutic use
Folate deficiency should be corrected, but B12 replacement should be started first to avoid worsening neurological damage
